Literature DB >> 8576316

Expression of CD44 variants in human inflammatory synovitis.

L P Hale1, B F Haynes, S S McCachren.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8576316     DOI: 10.1007/bf01541320

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


× No keyword cloud information.
  52 in total

1.  Regulation of human synovial fibroblast collagenase messenger RNA by interleukin-1.

Authors:  S S McCachren; P K Greer; J E Niedel
Journal:  Arthritis Rheum       Date:  1989-12

2.  THE FUNCTIONING OF THE DIFFUSE MACROMOLECULES OF JOINTS.

Authors:  M SCHUBERT; D HAMERMAN
Journal:  Bull Rheum Dis       Date:  1964-05

3.  Differentiation of human T lymphocytes. I. Acquisition of a novel human cell surface protein (p80) during normal intrathymic T cell maturation.

Authors:  B F Haynes; E A Harden; M J Telen; M E Hemler; J L Strominger; T J Palker; R M Scearce; G S Eisenbarth
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

4.  Characterization of the monocyte-specific esterase (MSE) gene.

Authors:  C C Uphoff; Z B Hu; S M Gignac; W Ma; F A Rainey; M Kreutz; W D Ludwig; H G Drexler
Journal:  Leukemia       Date:  1994-09       Impact factor: 11.528

5.  Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.

Authors:  G R Screaton; M V Bell; D G Jackson; F B Cornelis; U Gerth; J I Bell
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

6.  Participation in normal immune responses of a metastasis-inducing splice variant of CD44.

Authors:  R Arch; K Wirth; M Hofmann; H Ponta; S Matzku; P Herrlich; M Zöller
Journal:  Science       Date:  1992-07-31       Impact factor: 47.728

7.  Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages.

Authors:  P W Noble; F R Lake; P M Henson; D W Riches
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

8.  Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition.

Authors:  K Miyake; C B Underhill; J Lesley; P W Kincade
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

9.  A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps.

Authors:  K H Heider; M Hofmann; E Hors; F van den Berg; H Ponta; P Herrlich; S T Pals
Journal:  J Cell Biol       Date:  1993-01       Impact factor: 10.539

10.  Distinct effects of two CD44 isoforms on tumor growth in vivo.

Authors:  M S Sy; Y J Guo; I Stamenkovic
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

View more
  4 in total

1.  Expression of the matrix receptor CD44v5 on chondrocytes changes with osteoarthritis: an experimental investigation in the rabbit.

Authors:  C O Tibesku; T Szuwart; S A Ocken; A Skwara; S Fuchs
Journal:  Ann Rheum Dis       Date:  2006-01       Impact factor: 19.103

2.  A hexadecylamide derivative of hyaluronan (HYMOVIS®) has superior beneficial effects on human osteoarthritic chondrocytes and synoviocytes than unmodified hyaluronan.

Authors:  Margaret M Smith; Amy K Russell; Antonella Schiavinato; Christopher B Little
Journal:  J Inflamm (Lond)       Date:  2013-07-27       Impact factor: 4.981

3.  Pharmacological effects of N-[2-[[2-[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]ethyl]hyaluronamide (diclofenac Etalhyaluronate, SI-613), a novel sodium hyaluronate derivative chemically linked with diclofenac.

Authors:  Keiji Yoshioka; Tomochika Kisukeda; Ryoji Zuinen; Yosuke Yasuda; Kenji Miyamoto
Journal:  BMC Musculoskelet Disord       Date:  2018-05-22       Impact factor: 2.362

4.  Significant synovial pathology in a meniscectomy model of osteoarthritis: modification by intra-articular hyaluronan therapy.

Authors:  M M Smith; M A Cake; P Ghosh; A Schiavinato; R A Read; C B Little
Journal:  Rheumatology (Oxford)       Date:  2008-06-19       Impact factor: 7.580

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.